The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Assessment of Ki67 in relation to radiotherapy (RT) fractionation and prognosis in the CHHiP (CRUK/06/016) trial.
 
Anna Wilkins
No Relationships to Disclose
 
Barry Gusterson
No Relationships to Disclose
 
Zsolt Szijgyarto
No Relationships to Disclose
 
Joanne Haviland
No Relationships to Disclose
 
Clare Griffin
No Relationships to Disclose
 
Christine Stuttle
No Relationships to Disclose
 
Frances Daley
No Relationships to Disclose
 
Catherine M Corbishley
No Relationships to Disclose
 
David P. Dearnaley
Honoraria - Janssen; Sandoz; Takeda
Consulting or Advisory Role - Cadence Research and Consulting; FirstWord; Janssen; Janssen Research & Development; Sandoz; Takeda
Speakers' Bureau - Janssen; Janssen-Cilag
Patents, Royalties, Other Intellectual Property - Abiraterone acetate was developed at The Institute of Cancer Research, which therefore has a commercial interest in the development of this agent. Professor Dearnaley is on the Institute’s Rewards to Inventors list for abiraterone acetate. (Inst)
Expert Testimony - Vitality Life
Travel, Accommodations, Expenses - Janssen; Takeda
 
Emma Hall
Research Funding - Accuray (Inst); Alliance HealthCare Services (Inst); AstraZeneca (Inst); Aventis Pharma (Inst); Bayer Health (Inst); Kyowa Hakko Kirin (Inst)
 
Navita Somaiah
No Relationships to Disclose